Filing Analysis
Beneficient (BENF) issued 875,214 shares of Series B-10 Resettable Convertible Preferred Stock to a customer in exchange for a limited partner interest in an investment fund with a net asset value of $8.75 million. The transaction includes a monthly conversion price reset mechanism that could result in the issuance of up to 7.05 million Class A common shares.
Red Flags
- Resettable conversion price: The monthly reset to market price (down to a 35% floor) creates significant potential for dilution.
- Complex capital structure: The existence of at least ten series of 'B' preferred stock (B-1 through B-10) suggests a pattern of frequent, complex equity-linked transactions.
- Unregistered sale: The securities were issued in reliance on Section 4(a)(2) and Regulation D exemptions rather than a public offering.
Key Facts
- Transaction closed on April 8, 2026, involving the acquisition of an LP interest with an $8.75 million NAV.
- Issued 875,214 shares of Series B-10 Resettable Convertible Preferred Stock.
- Initial conversion price is set at $3.5479 per share.
- The conversion price resets monthly to the 5-day trailing VWAP, with a floor price of $1.2418 (35% of initial price).
- A maximum of 7,047,947 shares of Class A Common Stock may be issued upon conversion.
- The company reported an unrealized gain of approximately $1.2 million from the transaction.
- The Series B-10 ranks junior to Series A Preferred and pari passu with Series B-1 through B-9.
Beneficient reported the results of its 2026 Annual Meeting of Stockholders held on March 27, 2026. Shareholders re-elected three directors, ratified the company's independent auditor, and approved an amendment to increase the share reserve for the 2023 Long Term Incentive Plan.
Key Facts
- The Annual Meeting was held on March 27, 2026, with approximately 91.7% of total voting power represented.
- Stockholders re-elected Peter T. Cangany, Patrick J. Donegan, and Karen J. Wendel as Class A directors to serve until 2027.
- Weaver and Tidwell, LLP was ratified as the independent registered public accounting firm for the fiscal year ending March 31, 2026.
- An amendment to the Beneficient 2023 Long Term Incentive Plan (LTIP) was approved to increase the number of Class A common stock shares reserved for issuance.
- The LTIP Amendment became effective on March 27, 2026.
Beneficient (BENF) appointed Mack Hicks to its Board of Directors and entered into a settlement agreement with his firm, HH-BDH, LLC, to resolve $1.66 million in outstanding interest and fees. The settlement involves issuing 149,904 shares of Class A common stock and deferred cash payments totaling approximately $1.1 million.
Red Flags
- Related-party transaction involving a newly appointed director who controls the company's lender.
- Settlement of interest and fees using equity and deferred cash payments, which may indicate a strategy to preserve immediate liquidity.
- Significant concentration of ownership and influence by HH-BDH and Mack Hicks.
Key Facts
- Mack Hicks appointed to the Board of Directors effective March 10, 2026, pursuant to a 2023 Stockholders Agreement.
- Company settled $1.66 million in outstanding interest and fees with HH-BDH, LLC through a combination of stock and deferred cash.
- Issued 149,904 shares of Class A common stock valued at $572,588 based on a five-day VWAP.
- Agreed to pay $1,000,000 in cash by September 30, 2026, and $94,365 by March 31, 2026.
- HH-BDH, LLC holds 11,710,609 shares of Class A common stock and partnership interests with a $15.2 million capital account balance as of December 31, 2025.
- The $27.5 million principal of the underlying loan was previously repaid on January 12, 2026.